Avensina Medica Corp is categorized under Medical and Surgical Services Organizations in Houston, TX and active since 2006.
Avensina Medica Corp was established in 2006, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical and Surgical Services Organizations business, which does work in the B2C market, and is classified as a Medical and Surgical Services Organizations, under code number 5416120 by the NAICS.
If you are seeking more information, feel free to contact Carmen Neagu at the company’s single location by writing to 3730 Kirby Drive, Houston, Texas TX 77098 or by phoning (713) 831-6866. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Avensina Medica Corp |
| Contact Person: | Carmen Neagu |
| Address: | 3730 Kirby Drive, Houston, Texas 77098 |
| Phone Number: | (713) 831-6866 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical and Surgical Services Organizations |
| SIC Code: | 8099 |
| NAICS Code: | 5416120 |
| Share This Business: |
Avensina Medica Corp was started in 2006 to provide professional Medical and Surgical Services Organizations under the SIC code 8099 and NAICS code 5416120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Carmen Neagu for inquiries that concern Avensina Medica Corp by calling the company number (713) 831-6866, as your correspondence is most welcome. Additionally, the physical location of the single location of Avensina Medica Corp can be found at the coordinates 29.735616,-95.418754 as well as the street address 3730 Kirby Drive in Houston, Texas 77098.
For its online presence, you may visit Avensina Medica Corp’s website at and engage with its social media outlets through on Twitter and on Facebook.